News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Encysive Pharmaceuticals Reports Third Quarter 2006 Financial Results
November 2, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HOUSTON, Nov. 2, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the third quarter ended September 30, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Funding
Veradermics Gets $150M Series C to Advance Hair Regrowth Pill
October 16, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Q3 Layoffs Up 280% YOY With CSL, Merck, Novo’s Restructurings
October 16, 2025
·
4 min read
·
Angela Gabriel
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
October 15, 2025
·
2 min read
·
Dan Samorodnitsky
Funding
Pelage Pharmaceuticals Raises $120 Million To Grow Hair Loss Program
October 15, 2025
·
2 min read
·
Dan Samorodnitsky
